The Antiproliferative Properties of Uncaria tomentosa Willd. DC. extracts against Caco2 and HeLa Cancer Cell Lines

groupview

Abstract
Pharmacognosy Communications,2018,8,1,8-14.
Published:January 2018
Type:Original Article

The Antiproliferative Properties of Uncaria tomentosa Willd. DC. extracts against Caco2 and HeLa Cancer Cell Lines

Jaixi Shen1,2, Joseph Shalom1,3, Ian Edwin Cock1,3*

1School of Natural Sciences, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Queensland 4111, AUSTRALIA.

2School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, CHINA.

3Environmental Futures Research Institute, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Queensland 4111, AUSTRALIA.

Abstract:

Introduction: Uncaria tomentosa is used in Central and South American folk medicine to treat a variety of diseases. It is particularly well known for treating cancer and studies have confirmed its activity against some carcinoma cell lines. However, to date, U. tomentosa extracts have only been screened against a limited panel of cancer cells. Methods: Solvent extracts were prepared from U. tomentosa inner bark and their antiproliferative activities against Caco2 and HeLa cancer cells were determined by an MTS based cell proliferation assay. Toxicity was determined using the Artemia franciscana nauplii bioassay. Results: Methanolic and aqueous U. tomentosa extracts were strong inhibitors of Caco2 and HeLa cell proliferation, with IC50 values generally below 1500 μg/mL. The methanolic extract was particularly effective, with IC50 values of 881 and 763 μg/mL against Caco2 and HeLa cells respectively. In contrast, the mid to lower polarity solvent extractions (ethyl acetate, chloroform and hexane) were less potent inhibitors of cell proliferation. Indeed, exposure of the Caco2 cells to the chloroform and hexane extracts produced proliferation levels equivalent to those of the untreated control. Cell imaging studies detected morphological features consistent with apoptosis in Caco2 cells exposed to the methanolic and aqueous U. tomentosa extracts, indicating that these extracts are functioning by cytotoxic mechanisms. All U. tomentosa extracts were nontoxic in the Artemia franciscana bioassay, with LC50 values substantially >1000 μg/mL. Conclusions: The antiproliferative activity of the U. tomentosa inner bark extracts against HeLa and Caco2 cancer cell lines indicates their potential in the treatment and prevention of some cancers.

Founded:  In 2004, as the PHCOG.NET – a non-profit private organization dedicated to Natural Products Research leading to develop promising drugs. Our main mission is to make information on herbal drug research readily available in different formats to suit the individual needs.

Pharmacognosy Communications [Phcog Commn.] is a new quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the  publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.

The journal aims to cater the latest outstanding developments in the field of pharmacognosy and natural products and drug design covering but not limited to the following topics:

  • Pharmacognosy and pharmacognistic investigations
  • Research based ethnopharmacological evaluations
  • Biological evaluation of crude extracts, essential oils and pure isolates
  • Natural product discovery and evaluation
  • Mechanistic studies
  • Method and technique development and evaluation
  • Isolation, identification and structural elucidation of natural products
  • Synthesis and transformation studies

Distinctions:  The most widely read, cited, and known Pharmacognosy Communications and website is well browsed with all the articles published. More than 20,000 readers in nearly every country in the world each month

Aim and Scope | Editorial Board | Indexed & Abstracted | Instruction to Authors | Manuscript Submission & Charges

Subjects Covered : Natural Products, Pharmacognosy, Phytochemistry, Marine Pharmacognosy and Zoo Pharmacognosy
ISSN :2249-0159 (Print) ; 2249-0167 (Online) Frequency : Quarterly Rapid at a time publication (4 issues/year)

Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online  publication is 45 days.
Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.